Acasti names special advisor
This article was originally published in Scrip
Laval, Quebec-based Acasti Pharma, an emerging biopharmaceutical company focused on the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies, has named Jerald J Wenker as a special advisor to its board of directors. Mr Wenker – who is currently president and COO of Dermalogica, a skin care company based in the US – has also accepted a nomination for election to serve on Acasti's board at the next annual meeting to be held in 2014.
You may also be interested in...
Angeli Möller, recently spotlighted by In Vivo as a 2020 Rising Leader, has quickly moved up the ranks at Bayer and is now spearheading one of its key initiatives to bring artificial intelligence and machine learning technologies into the pharma business.
Coaching and mentoring are important tools for the leaders of today to be able to foster the next generation of talent in the biopharma sector. While the routes into industry have not changed dramatically – most leaders hold a master’s degree and/or PhD – the expectations of rising leaders have altered and the industry itself has become more collaborative.
In this first edition of In Vivo's ‘Rising Leaders’ list, the focus is on entrepreneurs and innovators who represent the next wave of creativity in health care.